Navigation Links
National Rehabilitation Hospital Team Calls Work of US Army's Europe Regional Medical Command Impressive
Date:6/20/2008

WASHINGTON, June 20 /PRNewswire-USNewswire/ -- A team of medical professionals from the National Rehabilitation Hospital is calling the U.S. Army's rehab services in Germany impressive. The NRH team has been in Germany since last weekend to work with the US Army's Europe Regional Medical Command (ERMC) in assessing their current rehabilitation practices.

"The integrity and capability of our military health care system to address the diverse and complex needs of our injured service members are impressive," says NRH Team leader John Brickley, Vice President at NRH for Ambulatory Services. "Just as in the civilian world, there are areas where improvements are possible, but midway through our tour, we have witnessed some excellent best practices at the Army's facilities."

The team will spend the next week making recommendations and suggestions for improving the quality and delivery of care given to injured soldiers and other military personnel. The Army's ERMC operates 15 ambulatory care centers in Germany which are the initial treatment sites for injured soldiers from Iraq. These ambulatory centers not only diagnose and provide treatment, but they determine the location of ongoing care for those soldiers wounded overseas.

In an effort to enhance its operations, the U.S. Army proactively reached out to NRH to gain additional insight and expertise in its continued commitment to promote an exceptional rehabilitation model.

"We are pleased to have NRH with us in Germany," notes Colonel Mary Lopez. "We share the same commitment as they do to develop comprehensive care plans so each and every one of our injured soldiers can return to their maximum capability and potential."

"The passion, commitment and skills of the Army's military health care providers and support personnel on the ground in Germany are clearly evident," adds Brickley.

The NRH Team

Jill Anderson, PT: Jill is a Regional Director in the NRH Medical Rehabi
'/>"/>

SOURCE National Rehabilitation Hospital
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Family Health International Awarded USAID Progress Project to Improve Family Planning and Reproductive Health Programs in Developing Countries
2. Changes in local health care markets affect national patient safety project
3. uKarma Corporation Commences International Distribution Agreement With Northern Response for its Xflowsion DVD Series
4. LPA Hosts 51st National Conference in Detroit
5. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
6. Pennsylvania Department of Health Confirms Fifth Salmonella Case Linked to National Outbreak
7. Indiana University to host national biorepository for gene therapy
8. National Campaign to Prevent Teen and Unplanned Pregnancy Statement on Jamie Lynn Spears
9. Washington Redskins Players, Kidney Disease Patients, Advocates Unveil National Petition Calling on Congress for Additional Kidney Care Support
10. Dilon Technologies Announces National Agreement with MedAssets
11. MedeFile Launches National Televised Ad Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... BROOK, Ill., Dec. 7 The University ... (AMC) members for their achievements in UHC,s Supply ... organizations are noted for modeling best practices in ... http://www.newscom.com/cgi-bin/prnh/20091207/CG21708 ) ,, The winners were determined ... that includes contract portfolio participation and use of ...
(Date:12/6/2009)... factor, researchers say , , SUNDAY, Dec. 6 (HealthDay ... the main tumor to other parts of the body ... which may prove a promising target for new drugs ... Previous studies have shown that TGFb (transforming growth factor ... new study, a team from Cancer Research UK used ...
(Date:12/6/2009)... 6 Blood clotting, or coagulation, is ... a blood vessel is injured. Sometimes, however, clots ... obvious injury or do not dissolve naturally, a ... at the 51st Annual Meeting of the American ... using the anticoagulants aspirin and heparin with the ...
(Date:12/5/2009)... has shown in a phase 1/2 clinical trial ... treatment of patients newly diagnosed with multiple myeloma, a ... researchers from Dana-Farber Cancer Institute. , Partial responses or ... treated with the drug combination in the multi-center study, ... rate" in the phase 2 population, reports Paul G. ...
(Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and often ... 51st Annual Meeting of the American Society of ... diagnostic methods for patients suffering from acute promyelocytic ... and myelofibrosis that are based on a better ...
Breaking Medicine News(10 mins):Health News:Recognized Top Performers in UHC Supply Chain 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... journal publisher, is proud to be participating in a ... today by the Council of Science Editors. , The ... stimulate interest and debate on the crucial matters of ... both developed and developing countries will simultaneously publish papers ...
... says, , , MONDAY, Oct. 22 (HealthDay News) -- If you,re ... says a common device can determine whether someone is a ... used to ferret out people who hide a cigarette ... show patients what smoking is doing to their bodies, he ...
... Late-breaking results from the ENDEAVOR IV trial, presented at ... Research Foundation, show that the Endeavor zotarolimus-eluting stent met ... profile (equivalent rates of death, heart attack, and repeat ... , In addition, the Endeavor stent showed a ...
... Bayer Consumer Care announces,the availability of the ... Sinus), combining a long-lasting nasal decongestant with the,pain-relieving ... from,multiple sinus and pain symptoms. The combination ... in a recent survey of adults who suffer ...
... of,the nation,s leading information systems publications, has ranked ... top 500 innovators of information,technology. Highmark, which ... and,fourth in the insurance industry overall, moved up ... Tabor, Highmark,s senior vice president of information services ...
... than four percent lower, BLOOMINGTON, Minn., Oct. ... provide new evidence that members,who have health savings ... and are more engaged in seeking out more ... adjusted for illness burden, health,care costs were 4.4 ...
Other Medicine News:Health News:9 SAGE journals participate in global theme issue on poverty and human development 2Health News:Blood Test Catches Secret Smokers 2Health News:Blood Test Catches Secret Smokers 3Health News:ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 2Health News:ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication 3Health News:National Magazine Ranks Highmark 62nd Among Nation's 500 Most Innovative Users of Information Technology 2Health News:New Study Shows Lower Costs, Increased Consumer Engagement in Account-Based Health Plans 2
(Date:12/4/2009)... inexpensive computer tool that measures volume changes in the ... by a CT scanner can rule out non-cancerous ones ... true cancers with fewer, less expensive and less invasive ... diagnostic guidelines are described in a paper published yesterday ...
(Date:12/4/2009)... Vermillion, Inc. (VRML) (Pink Sheets: VRMLQ) announced that on ... Reorganization and related amended Disclosure Statement with the United States ... A hearing to consider the adequacy of the Disclosure Statement ... on the confirmation of the Plan scheduled for January 7, ...
(Date:12/4/2009)... 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... and webcast. Principal investigators will discuss the data ... as featured at the 51st American Society of Hematology ... 9:00 a.m. CT/10:00 a.m. ET on Monday, December 7, ...
Breaking Medicine Technology:European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex 28R 29 12913 1China Clean Energy Provides Business Update 12912 1China Clean Energy Provides Business Update 12912 2China Clean Energy Provides Business Update 12912 3US Farms Inc Showcasing Aloe Vera Product Line at Natural MarketPlace 2009 50872 1US Farms Inc Showcasing Aloe Vera Product Line at Natural MarketPlace 2009 50872 2
... able to stimulate insulin,release, TARRYTOWN, N.Y., March ... today results of two clinical,studies conducted in ... Gastroenterology and Hepatology,University Hospital Basel in Basel, ... peptide-1 (7-36 amide) (GLP-1) was to,establish the ...
... Survey Shows 89% of Patients Prefer Orapred ... 2007 /PRNewswire/ -- Alliant,Pharmaceuticals announced today survey ... sodium phosphate,orally disintegrating tablets) over liquid steroids.(1) ... survey involving more than,900 children (n=973), showed ...
Other Medicine Technology:Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 2Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 3Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 4Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 5Orapred ODT Tastes Good 2Orapred ODT Tastes Good 3
... an integral part of the enzymatic cascade ... as well as the degradation of Bradykinin. ... is primarily located in endothelial cells. ACE ... for sarcoidosis and myocardial infarction but is ...
... and quantitative evaluation of pancreatic b-cell function is ... post-diagnostic study of the natural history of diabetes ... as a guide to the correct choice of ... to assess b-cell function because of the ...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
... quantitative evaluation of pancreatic -cell function is not ... study of the natural history of diabetes mellitus, ... a guide to the correct choice of treatment. ... -cell function because of the large and variable ...
Medicine Products: